Calyxt, Inc. (CLXT) Bundle
Imagine a company born in 2010 in Roseville, Minnesota that aims to reshape what's on our plates by using its proprietary TALEN gene‑editing platform to create tangible food innovations-think low trans fat soybean oil, cold‑storable potatoes, gluten‑reduced wheat and low‑saturated canola-while pursuing a vertically integrated mission to deliver healthier, better‑tasting and more sustainable crops; since its 2015 rebrand from Cellectis Plant Sciences, Calyxt has emphasized partnerships and a core set of values-integrity, innovation, sustainability, collaboration and accountability-that drive its vision to become the world leader in healthy, sustainable food solutions and guide its efforts to improve nutrition, yield and environmental impact across the food system
Calyxt, Inc. (CLXT) - Intro
Calyxt, Inc. is a biotechnology company focused on applying advanced gene‑editing technologies to create healthier, higher‑performing and more sustainable food and crop products. Founded in 2010 and headquartered in Roseville, Minnesota, Calyxt uses its proprietary TALEN gene‑editing platform to make targeted, heritable edits in plant genomes to improve nutritional profiles, processing characteristics, shelf life and agronomic performance.- Founded: 2010 (Roseville, MN headquarters)
- Rebranded from Cellectis Plant Sciences, Inc. to Calyxt in 2015 to reflect exclusive agricultural focus
- Core technology: TALEN-based gene editing for precise, non-transgenic modifications
- Primary product programs: soybean, potato, wheat, canola (four active commercial/advanced programs)
| Product / Program | Trait / Objective | Commercial Status |
|---|---|---|
| Low trans fat soybean oil | Reduced trans fat via altered oil composition for food processing | Commercial / Market partnerships for manufacturing and distribution |
| Cold‑storable potato | Lower reducing sugars, improved cold storage and processing fry color | Commercial launches with channel partners |
| Gluten‑reduced wheat | Reduction of immunogenic gluten peptides to expand use for sensitive consumers | Development / advanced breeding stages |
| Low‑saturated canola oil | Lower saturated fat profile to improve cardiovascular nutrition metrics | Development / pathway to commercialization |
- Product commercialization: advancing trait pipelines through breeding, scale‑up and partner channels to deliver ingredient‑level benefits to food manufacturers and producers.
- Partnerships: leveraging industry collaborations to access processing, distribution and go‑to‑market capabilities while reducing capital intensity.
- Regulatory and stewardship: navigating trait approvals and voluntary registration pathways to enable market access across geographies.
- Sustainability: targeting reduced food waste, improved input efficiency and better nutritional outcomes as measurable environmental and public‑health contributions.
- Core commercial product classes in market or advanced rollout: 4 crop/trait families (soybean oil, potato, wheat, canola).
- Technology approach: TALEN gene editing to introduce precise, heritable edits without transgenic constructs.
- Market approach: B2B ingredient sales and strategic partner distribution to scale adoption in food manufacturing and agricultural supply chains.
Calyxt, Inc. (CLXT) - Overview
Calyxt's mission is to transform food with vertically integrated gene-editing technologies, delivering healthier and better-tasting products, with higher-yielding and more sustainable crops, for better, easier, and more efficient food production for all. This mission underscores the company's commitment to leveraging advanced biotechnology to improve food quality and agricultural practices. By focusing on gene-editing technologies, Calyxt aims to address global challenges related to nutrition and sustainability in the food industry. The emphasis on 'vertically integrated' processes indicates Calyxt's approach to controlling the entire development cycle, from research to commercialization. The mission reflects a dedication to making food production more efficient, aligning with the growing demand for sustainable agricultural solutions. Calyxt's mission statement has remained consistent over time, highlighting its unwavering focus on innovation and sustainability in the food sector.- Founded: 2010; Headquarters: Roseville, Minnesota; Public ticker: CLXT
- Core technology: CRISPR/Cas and TALEN-enabled gene editing for trait development in crops and ingredient platforms
- Vertical integration: in-house trait discovery, breeding, field testing, and product commercialization
- Research & development: iterative gene-editing cycles to produce target traits (yield, quality, shelf-life, nutrition)
- Trait validation: multi-site agronomy trials and compositional analysis to meet regulatory and commercial specifications
- Commercialization: seed production, license arrangements, supply-chain partnerships, and branded ingredient channels
| Metric | Relevant Figure / Source |
|---|---|
| Projected global food demand increase by 2050 | ~60% (FAO/World Bank estimates) |
| Global population (2024) | ~8.1 billion |
| Food system GHG contribution | ~21-37% of global emissions depending on scope (IPCC & FAO estimates) |
| Typical yield gap in staple crops (variable by region) | 20-50% yield increases achievable with improved genetics and practices |
| Gene-editing adoption potential | Regulatory pathways accelerating in multiple markets (US, Brazil, Argentina, parts of Asia) |
| Calyxt corporate facts | Founded 2010; HQ Roseville, MN; publicly listed as CLXT |
- Science-driven innovation - investing in robust trait development and validation
- Transparency & stewardship - field data, regulatory compliance, and supply-chain traceability
- Sustainability - targeting yield, input-efficiency, and reduced waste
- Customer-centricity - tailoring traits to food manufacturers, growers, and consumers
- Integrity & safety - adhering to biosafety, regulatory, and ethical standards
- Pipeline diversity - multiple trait targets spanning oilseeds, pulses, and specialty crops (R&D-stage through field trials)
- Partnerships - collaborations with breeders, processors, and ingredient customers to accelerate commercialization
- Regulatory engagement - utilizing established regulatory frameworks for gene-edited crops to enable market entry
Calyxt, Inc. (CLXT) Mission Statement
Calyxt, Inc. (CLXT) envisions becoming the world leader in healthy and sustainable food solutions - a clear, long-term aim that has guided strategy since the company's rebranding in 2015. This vision frames Calyxt's pursuit of innovation in plant biology and gene editing to deliver healthier ingredients, reduce environmental impacts, and address shifting consumer preferences toward health-conscious and eco-friendly food choices.- Founded: 2008 (rebranded to Calyxt in 2015)
- Headquarters: Roseville, Minnesota; Nasdaq ticker: CLXT
- Core technological platform: precision gene editing for crop trait development
- Strategic focus: commercialize seed and ingredient solutions that improve nutrition and sustainability
- Mission: Develop and commercialize plant-based products and trait solutions that enable healthier diets and lower environmental footprint.
- R&D emphasis: accelerate trait-to-market timelines via precision editing to deliver differentiated crop inputs and specialty ingredients.
- Commercial approach: partner with food manufacturers, ingredient buyers, and growers to scale delivery and adoption.
- Consumer trends: sustained worldwide rise in demand for healthier, minimally processed, and sustainably produced foods - a central market tailwind for Calyxt's offerings.
- Industry opportunity: growing interest from food companies and ingredient formulators for crop-based solutions that can improve nutritional profiles (e.g., reduced trans fats, improved oil profiles) and sustainability metrics.
| Attribute | Detail |
|---|---|
| Established | 2008 |
| Rebranded | 2015 |
| Headquarters | Roseville, MN |
| Public listing | Nasdaq: CLXT |
| Technology focus | Precision gene editing for crop trait development |
- Science-driven innovation - sustained investment in R&D to convert trait science into commercial products.
- Health-first design - prioritize nutritional improvements that deliver measurable consumer health benefits.
- Sustainability - reduce inputs, improve resource efficiency, and lower environmental footprints through trait improvements.
- Partnership and commercial execution - collaborate across the value chain (growers, processors, brands) to scale solutions.
- Regulatory and stewardship responsibility - ensure rigorous compliance and responsible deployment of gene-edited traits.
| KPI | Relevance to Vision |
|---|---|
| Number of commercialized traits | Direct measure of product pipeline translating to market-impacting healthier ingredients |
| Partnerships with food manufacturers/processors | Indicator of route-to-market and adoption velocity |
| Seed/ingredient revenue growth | Financial realization of R&D and commercialization strategy |
| Environmental metrics (e.g., reduced inputs per acre) | Quantifies sustainability benefits delivered by traits |
- Health & nutrition: Calyxt's focus on improved oil and crop trait profiles meets growing demand for healthier ingredient alternatives.
- Sustainability: Trait-enabled reductions in inputs and processing align with corporate sustainability goals across the food industry.
- Regulatory evolution: As gene-editing clarity advances globally, Calyxt's science-first approach positions it to capture accelerating market opportunities.
Calyxt, Inc. (CLXT) - Vision Statement
Calyxt, Inc. (CLXT) envisions a future where precision plant biology delivers healthier, more sustainable food and industrial solutions at scale. The company's vision centers on transforming agriculture and food systems through proprietary gene-editing and plant-breeding platforms to create differentiated traits that reduce environmental impact, improve nutritional outcomes, and open new commercial markets.- Core value: Integrity - Calyxt commits to ethical conduct, regulatory transparency, and stewardship in R&D and commercialization.
- Core value: Innovation - Continuous investment in proprietary gene-editing platforms and trait pipelines keeps Calyxt competitive in biotechnology.
- Core value: Sustainability - Products and operations prioritize reduced inputs, lower carbon footprint, and supply-chain resilience.
- Core value: Collaboration - Cross-functional teams and external partnerships accelerate product development and market access.
- Core value: Accountability - Clear metrics, governance, and performance culture hold teams responsible for milestones and financial discipline.
- Accelerate commercial launches of specialty crops and trait-enabled ingredients with clear sustainability and nutritional claims.
- Expand licensing and partnership arrangements to monetize platform technology and diversify revenue streams.
- Maintain rigorous compliance and transparent stakeholder communications to build long-term trust among investors, customers, and regulators.
- Invest in scalable manufacturing and supply-chain partnerships to ensure product availability and reduce time-to-market.
| Metric | Data |
|---|---|
| Founded | 2010 |
| Headquarters | Roseville, Minnesota |
| Public listing (Ticker) | NASDAQ: CLXT (IPO 2017) |
| Approx. employees | ~50-60 (corporate & R&D as reported in recent filings) |
| FY 2023 Revenue | $5.2 million (product sales, licensing & services) |
| FY 2023 Net Loss | ~$28.4 million (R&D and operating expenditures) |
| Cash & cash equivalents (FY 2023) | $15.1 million |
- Integrity - Quarterly SEC filings, governance disclosures, and audit controls; board oversight tied to compliance metrics.
- Innovation - R&D spend as a percentage of revenue (historically high in early commercialization years) and pipeline counts (number of advanced trait programs).
- Sustainability - Product claims quantified by reduced pesticide/fertilizer input potential, lifecycle emissions improvements, and supplier sustainability commitments.
- Collaboration - Number of active partnerships and licensing agreements; co-development milestones and revenue-sharing arrangements.
- Accountability - Milestone-driven budgets, go/no-go decision points for programs, and investor updates aligned with KPIs.
- Product development - Trait pipelines prioritized by environmental benefit and market demand, with cross-functional teams (R&D, regulatory, commercial) jointly accountable for launch timelines.
- Partnerships - Strategic collaborations to scale manufacturing and distribution, sharing both technical risk and commercial upside.
- Governance - Transparent reporting cadence and adherence to regulatory guidance to maintain stakeholder confidence during product approvals and commercialization.
Calyxt, Inc. (CLXT) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.